The maternie Database:
We collect a lot of women’s health news, every weekday. This is where you’ll find everything we’ve rounded up and reported on menopause. Want to get this news in your inbox, as soon as we find it? Sign up above.
Axios investigates gaps in menopause education and training for healthcare providers.
The New Yorker reviews three celebrity books about menopause and explores historical menopause “moments.”
Halle Berry speaks with Time about her plans to push for improved menopause treatment and increased emphasis on menopause education in medical schools.
Cheryl Wishhover delivers a witty review of celebrity menopause products, questioning their true benefits and efficacy.
Oregon lawmaker Shelly Boshart Davis recounts her personal experience of being denied menopause care and advocates for insurer coverage of hormone therapy.
A systematic review suggests acupuncture may help manage menopausal insomnia—with few side effects, though the evidence is rated low to moderate.
The New York Times investigates whether testosterone therapy could benefit menopausal women.
Women voice frustrations over intrusive social media ads during perimenopause.
A panel discussion featured in The American Journal of Managed Care explores how sleep disturbances during menopause significantly impact women’s health – even if they aren’t hot flashes.
A recent documentary on menopause made a big splash, but some experts are criticizing it for overstating the risks of cancer and heart disease associated with hormone replacement therapy.
How hormonal changes during menopause, particularly the decline in estrogen levels, can lead to muscle pain and body aches.
Last year, the same agency got fierce criticism for saying menopausal woman should get talk therapy
A deep dive on the queen of menopause, Dr. Mary Claire Haver, and her push to get more women treatment for menopause symptoms.
Eliza Barclay has a reported essay on her experience with several muscle injuries in her 40s
How the physician leading the Menopause Society went from thinking “that asking for additional provisions for women would fuel more gender discrimination — if women required special treatment, employers would have more reason to not hire or promote them” to building a plan.
Digging in to the exceedingly low hormone replacement therapy numbers among American women aged 50-59, with less than four percent using the treatment.
An overview of where things stand in menopause care in America.
Hormone therapy has dropped significantly since 2007 across all age groups of potentially menopausal women, according to research presented at the Menopause Society’s annual meeting in Chicago.
What rapamycin could do for millions of women.
STIs among older adults are on the rise.